meowdini
Novo Nordisk CEO Faces Scrutiny Over High Prices for Weight-Loss Drugs in the US
Novo Nordisk's CEO Lars Fruergaard Jørgensen defends the high prices of Wegovy and Ozempic during a US Senate hearing.
top of page
Meowdini Mews
bottom of page